Pfizer recalls three lots of Effexor XR
Pharmaceutical major Pfizer has issued nationwide recall for three lots of Effexor XR, a widely used antidepressant after a pharmacist reported the bottle of Effecor XR containing a capsule of Tikosyn. Pfizer has issued voluntary recall for one lot of 90-count Effexor XR (venlafaxine HCl) 150 mg extended-release capsules and one lot of 90-count Greenstone LLC-branded Venlafaxine HC1 150 mg extended-release capsules.
The U.S. Food and Drug Administration has confirmed the recall issued by Pfizer. The FDA release informs that there is very low probability of Effexor ER supply containing Tikosyn capsule.
As a precaution, the company has recalled three lots. The use of Tikosyn by Effexor XR patient can cause adverse health consequences. The company has not received any reports so far from consumers.
Tikosyn is a Class III antiarrhythmic medicine. The drug is prescribed to atrial fibrillation and atrial flutter AFL patients and to maintain normal heartbeat.
The company has asked distributors and wholesalers to stop any further distribution of the product under recall. The network agents have been asked to return the product to Stericycle Inc and retailers have been urged to inform consumers in case they have sold medications from the concerned lot.
The Pfizer lot numbers V130142 and V130140 have expiry date of October 2015. The Greenstone lot number V130014 carries expiry date of August 2015.
For more information, Pfizer can be contacted at 1-800-438-1985. Stericycle Inc. support team will be available at 1-888-345-0481.
A 93-year-old man was recently reported missing...Read More